Kolinsky Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,497
Closed -$218K 160
2024
Q1
$218K Buy
+2,497
New +$213K 0.17% 133
2023
Q4
Sell
-4,442
Closed -$348K 141
2023
Q3
$348K Buy
4,442
+326
+8% +$27.3K 0.35% 69
2023
Q2
$357K Buy
4,116
+549
+15% +$47.3K 0.34% 74
2023
Q1
$288K Buy
3,567
+263
+8% +$21.4K 0.31% 84
2022
Q4
$257K Buy
3,304
+243
+8% +$19.7K 0.29% 94
2022
Q3
$247K Sell
3,061
-215
-7% -$19.3K 0.31% 88
2022
Q2
$294K Buy
3,276
+123
+4% +$12.5K 0.35% 73
2022
Q1
$350K Buy
3,153
+611
+24% +$64.6K 0.34% 61
2021
Q4
$263K Buy
+2,542
New +$294K 0.24% 111

Other funds holding MDT

Kolinsky Wealth Management's MDT Position: Q2 2024 in Review

Kolinsky Wealth Management sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,497 shares — an estimated $218K sold.

Kolinsky Wealth Management first reported a position in MDT in Q4 2021 and held it in 9 quarters. The position peaked at $357K in Q2 2023. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Kolinsky Wealth Management reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Kolinsky Wealth Management sold 2,497 Medtronic shares in Q2 2024, an estimated $218K.
  • Kolinsky Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 9 quarters.
  • Kolinsky Wealth Management's Medtronic position peaked at $357K in Q2 2023.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Kolinsky Wealth Management's 13F filing for Q2 2024, filed 14 Aug 2024.